Rights and permissions
About this article
Cite this article
Insulin: basal-bolus more cost effective than premixed for T2DM. Pharmacoecon. Outcomes News 634, 9 (2011). https://doi.org/10.2165/00151234-201106340-00022
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106340-00022